Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 22, 2024CancersOpen Access

Immunotherapy and Cannabis: A Harmful Drug Interaction or Reefer Madness?

View Full Paper
Ask AI
Bookmark
Share

Authors

BPBrian J. PiperMTMaria TianPSPragosh Saini

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Piper et al. (2024) studied this question.

synapsesocial.com/papers/68e72babb6db6435876a5ae6https://doi.org/10.3390/cancers16071245
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome2020 · 138 citations
  2. 2Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies2019 · 152 citations
  3. 3Examining the risk of immune checkpoint inhibitor-related toxicity among patients with melanoma and their history of cannabis use.2024
  4. 4Abstract 6293: Influence of prescription opioids and recreational cannabis use on efficacy outcomes and adverse events related to immune checkpoint inhibitors2024
  5. 5Cannabis use among patients receiving immune checkpoint inhibitors.2025